Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Regenerative Medicine
  4. Persistence of ­FoxJ1+ ­Pax6+ ­Sox2+ ependymal cells throughout life in the human spinal cord

Persistence of ­FoxJ1+ ­Pax6+ ­Sox2+ ependymal cells throughout life in the human spinal cord

Cellular and Molecular Life Sciences, 2023 · DOI: https://doi.org/10.1007/s00018-023-04811-x · Published: June 17, 2023

Regenerative MedicineNeurologyGenetics

Simple Explanation

Ependymal cells, which line the central canal of the spinal cord, are important for creating a physical barrier and helping cerebrospinal fluid circulate. These cells express specific transcription factors like FOXJ1 and SOX2. This study investigated whether these cells persist throughout life in humans. The researchers examined spinal cords from 17 organ donors aged 37–83 years. They used immunohistochemistry to look for cells expressing FOXJ1, SOX2, and PAX6, as well as proteins involved in cilia function (RFX2 and ARL13B). The study found that cells expressing FOXJ1, SOX2, and PAX6 were present in the central region of the spinal cord in all cases, even in older individuals. Some donors also showed a fetal-like organization of neurodevelopmental transcription factors in the ependymal cells.

Study Duration
Not specified
Participants
17 organ donors aged 37–83 years
Evidence Level
Not specified

Key Findings

  • 1
    FOXJ1+ cells, co-expressing SOX2 and PAX6, persist in the central region of the spinal cord throughout human life, even in donors aged 37-83 years.
  • 2
    Ependymal cells in aged spinal cords express cilia-associated proteins ARL13B and RFX2, indicating the maintenance of cilia-related functions.
  • 3
    A fetal-like regionalization of neurodevelopmental transcription factors (MSX1, ARX, FOXA2) can be observed in the ependymal cells of some older donors (>75 years), with dorsal and ventral expression patterns.

Research Summary

The study investigated the persistence of ependymal cells in the human spinal cord during aging, examining spinal cords from 17 organ donors aged 37-83 years. The findings demonstrate that ependymal cells expressing FOXJ1, SOX2, PAX6, ARL13B, and RFX2 are maintained in the spinal cord throughout life, even in older individuals. The study also reveals heterogeneity among ependymal cells and suggests that the obliteration of the central canal is not uniform throughout the spinal cord.

Practical Implications

Understanding Ependymal Cell Maintenance

The study provides new evidence for the persistence of ependymal cells throughout human life, challenging previous notions of their disappearance with age. This understanding is crucial for exploring their potential roles in spinal cord health and disease.

Exploring Regenerative Potential

The maintenance of ependymal cells with immature traits suggests a potential for regeneration in spinal cord injuries or degenerative diseases. Further research is needed to clarify their regenerative capabilities and how they can be harnessed for therapeutic purposes.

Standardizing Research Protocols

The variability in findings across studies highlights the need for standardized protocols for collecting and analyzing human spinal cord samples. This will improve the reliability and comparability of future research on ependymal cells and spinal cord health.

Study Limitations

  • 1
    Technical variability among samples due to non-standardized collection and diverse clinical histories.
  • 2
    Variation in postmortem intervals until sample collection.
  • 3
    Inability to demonstrate maintenance of proliferation and differentiation capacities in aged ependymal cells.

Your Feedback

Was this summary helpful?

Back to Regenerative Medicine